APDN, Cornell University College of Veterinary Medicine Research Collaboration
September 8th, 2022
Tag: Veterinary
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
Long Island company shifts COVID-19 vaccine trial focus from cats to mink
September 2nd, 2021
Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
June 7th, 2021
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021